Traditional Chinese Medicine Combined With Entecavir to Treat Refractory Liver Fibrosis in Liver Cirrhosis Due to HBV

Clinical trial NCT02241616 · UNKNOWN

Trial details

NCT number: NCT02241616
Sponsor: ShuGuang Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis B Virus Related Cirrhosis

Start date: 2014-09-01
Primary completion: 2019-06-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.